Drug Trial Radar · NCT01256424
Dose-finding Study of Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) to Treat Cervical Neoplasia
Last checked: Nov 20, 2026Latest source record: May 16, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
262
Actual
Start
Apr 2011
Primary completion
Sep 2012
Study completion Dec 2012
Sponsor
- Lead sponsor
- PhotocureIndustry
- Sponsor type
- Industry
- First posted
- Dec 8, 2010
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
An effective and safe medical therapy would be most welcome to reduce the need for surgical interventions and related adverse events and psychological impact on patients with cervical cancer precursors. In this clinical trial, the investigators propose to evaluate the efficacy and safety of photodynamic therapy (PDT) using hexaminolevulinate (HAL) for mild to moderate-grade CIN (grade 1-2).
Conditions
- Cervical Intraepithelial Neoplasia
Interventions
HAL 5% with illuminationDrug
Treatment with a singe dose of 2g, HAL 5% ointment followed by photoactivation
HAL 1% with illuminationDrug
Treatment with a singe dose of 2g, HAL 1% ointment followed by photoactivation
HAL 0.2% with illuminationDrug
Treatment with a singe dose of 2g, HAL 0.2% ointment followed by photoactivation
Placebo ointment without illuminationDrug
Treatment with a singe dose of 2g placebo ointment, no photoactivation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Comparison of Lesion Response Rates of Three Different Doses of HAL PDT and Placebo at 3 Months After Treatment.Time frame: 3 months after last treatment
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
University Hospital Hannover
Hanover, Germany
Haukeland University Hospital
Bergen, Norway
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.